Kristine De Dios

This inventor holds 10 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Ambrx, Inc.. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kristine De Dios. Retrieved from https://idiyas.com/inventor/kristine-de-dios

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 6.0

ph-index = 6

Forward Citations = 91(Granted Patents)

Company Filing History:

10 out of 117

Ambrx, Inc.

patents

Years Active: 2014-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11786578 - Modified relaxin polypeptides and their uses (2023-10-17),

2. 11439710 - Nucleic acids encoding modified relaxin polypeptides (2022-09-13),

3. 11311605 - Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptides (2022-04-26),

4. 10751391 - Methods of treatment using modified relaxin polypeptides comprising a non-naturally encoded amino acid (2020-08-25),

5. 10702588 - Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chain (2020-07-07),

6. 10253083 - Therapeutic uses of modified relaxin polypeptides (2019-04-09),

7. 9962450 - Method of treating heart failure with modified relaxin polypeptides (2018-05-08),

8. 9567386 - Therapeutic uses of modified relaxin polypeptides (2017-02-14),

9. 9452222 - Nucleic acids encoding modified relaxin polypeptides (2016-09-27),

10. 8735539 - Relaxin polypeptides comprising non-naturally encoded amino acids (2014-05-27),

Title: Innovations by Kristine De Dios

Introduction

Kristine De Dios is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of modified relaxin polypeptides. With a total of 10 patents to her name, her work has the potential to impact various medical treatments.

Latest Patents

One of her latest patents focuses on modified relaxin polypeptides and their uses. This patent provides exemplary embodiments of relaxin polypeptides that include one or more amino acid substitutions with natural or non-naturally encoded amino acids. Additionally, it discusses the linkage of these polypeptides to water-soluble polymers, such as polyethylene glycol. The use of these relaxin polypeptides is particularly aimed at treating diseases, including heart failure.

Career Highlights

Kristine De Dios is currently associated with Ambrx, Inc., where she continues to innovate in her field. Her work is characterized by a commitment to advancing medical science through her research and inventions.

Collaborations

Throughout her career, Kristine has collaborated with notable colleagues, including Vadim Kraynov and Nick Knudsen. These partnerships have further enhanced her research and development efforts.

Conclusion

Kristine De Dios exemplifies the spirit of innovation in biotechnology, with her patents paving the way for new treatments in medicine. Her contributions are invaluable to the scientific community and hold promise for future advancements.

Profile summary based on public USPTO records.